novelty pharma gdd sa
Novelty Pharma - 躍動する医薬品イノベーション
発泡性医薬品イノベーション 会社に関する詳細情報 当社は 25 年以上にわたって医薬品と栄養補助食品を開発してきました。当社は、未来を予測するという使命を掲げ、医薬品、栄養学、化粧品に特化したヘルスケア分野の卓越したセンターです。市場の動向に常に注意を払うことで、当社はイノベーションを推進し、最先端の製品を生み出しています。
- Type
- manufacturer (our classification of the record, not a statement by the company)
- Role
- Manufacturer
- Location
- Cadempino, Switzerland
- Website
- https://www.noveltypharma.com
- Categories
- 医薬品製造, 医療およびヘルスケア用品, サプリメントとウェルネス
Listed in a source registry
What is established and what is not
No facet of this company has been investigated yet. The facts below are collected records, not an assessment: nothing here confirms manufacturing, ownership or trading status beyond what each record literally says.
Verified facts
- domain-registered (green), checked 2026-08-02 Domain registry record
- web-presence-since (green), checked 2026-08-03 Internet Archive (Wayback)
- sanctions-clear (green), checked 2026-07-21 - screened by name only: no legal entity is established for this record, so this is not a clearance OpenSanctions
Import rules for these goods
- Food supplements sold in the EU follow Directive 2002/46/EC: most member states require a notification to the national authority before the first sale. European Commission (supplements)
- Medical devices sold in the EU must carry CE marking under the Medical Device Regulation (EU) 2017/745, with a conformity assessment matched to the device risk class. European Commission (MDR)
- For the US market, the maker must have an FDA device establishment registration and product listing; most instruments also need 510(k) premarket clearance. US FDA (devices)
- Medicines imported into the EU must come from a site holding an EU GMP certificate, and the importer needs a manufacturing/import authorisation. European Medicines Agency (GMP)